Innovating Works

Tagworks

Desconocido
bioSWITCH: Bioorthogonal Implantable Iontronic Switch to Temporally Control the Local Release of Chemotherapeut... TAGWORKS PHARMACEUTICALS BV participó en un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Our vision for a new type of cancer treatment is based on an implantable therapeutic system capable of ‘programmable’ on-demand delivery of...
2022-12-20 - 2026-02-28 | Financiado
PET-AlphaSy: PET Imaging of Alpha Synuclein Fibril Formation TAGWORKS PHARMACEUTICALS BV participó en un H2020: H2020-MSCA-ITN-2018 Too often, physicians have to rely on a trial and error strategy until the most effective treatment for an individual patient is identified....
2018-08-30 - 2022-11-30 | Financiado
THERACAT: Bio orthogonal catalysis for cancer therapy TAGWORKS PHARMACEUTICALS BV participó en un H2020: H2020-MSCA-ITN-2017 THERACAT is an international and multidisciplinary consortium aiming at the training of 13 ESRs on the innovative topic of novel bio-orthogo...
2018-04-04 - 2022-08-31 | Financiado
Click-It: In Vivo Click PET Imaging Agents Improving clinical companion diagnostics TAGWORKS PHARMACEUTICALS BV participó en un H2020: H2020-PHC-2014-2015 Companion diagnostics are crucial for drug development and disease management with regard to patient selection, therapy planning and monitor...
2015-12-02 - 2021-06-30 | Financiado
PRISAR: Preclinical Intra Operative Image Guided Surgery and Post Operative Radiotherapy of Tumours TAGWORKS PHARMACEUTICALS BV participó en un H2020: H2020-MSCA-RISE-2014 The main objective and basic concept of our proposal is to improve intra-operative and post-operative targeted surgical probes and new detec...
2014-12-01 - 2019-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.